A US senator has accused Wyeth of having journal articles about its hormone therapy products ghostwritten and then signed by the authors. In a letter to the US drug major, Sen Charles Grassley (Republican, Iowa) suggests that the practice of having manuscripts developed by a drug company either by itself or through a third-party could lead to biased information.
Sen Grassley wrote that "some medical literature may be subtle advertisements rather than publications of independent research. The information in these articles can have a significant impact on doctors' prescribing behavior and, in turn, on the American taxpayer, because the Medicare and Medicaid programs pay billions of dollars for prescription drugs. Thus, any attempt to manipulate the scientific literature, that can in turn mislead doctors to prescribe drugs that may not work or cause harm to patients, is very troubling."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze